Ligand validation:7LJE

Y2P: 2-[4-[(3'R,4S)-3'-fluoro-1-[2-[(4-fluorophenyl)methyl-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]amino]-2-oxo-ethyl]-2,5-dioxo-spiro[imidazolidine-4,1'-indane]-5'-yl]pyrazol-1-yl]-N-methyl-acetamide

Y2P is a Ligand Of Interest in 7LJE designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7LJE_Y2P_C_1701	59%	63%	0.165	0.949	0.48	0.91	-	3	0	0	100%	1
7LJE_Y2P_A_1701	58%	69%	0.168	0.947	0.38	0.79	-	3	0	0	100%	1
7LJE_Y2P_B_1701	51%	69%	0.173	0.929	0.38	0.78	-	2	2	0	100%	1
7LJE_Y2P_D_1701	49%	70%	0.178	0.925	0.32	0.79	-	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.